Leading Financial Service Provider in India | Canara Bank Securities Ltd

Mankind Pharma Ltd.

Jul 24 BSE 2505.40 ( -51.70 -2.02%)

Volume6973

Prev. Close
2557.10

Open Price
2556.20

Today's Low / High

2501.55 2556.20

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

1909.90 2670.00

Jul 24 NSE 2507.20( -50.20 -1.96%)

Volume186027

Prev. Close
2557.40

Open Price
2548.00

Today's Low / High

2501.30 2554.80

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

1909.70 2674.00

Market Cap. ( ₹ in Cr. )	103546.35	P/BV	6.35	Book Value ( ₹ )	394.69
52 Week High/Low ( ₹ )	2674/1910	FV/ML	1/1	P/E(X)	54.13
Book Closure	08/08/2025	EPS ( ₹ )	46.32	Div Yield (%)	0.04

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	4128.28	4125.79	4005.88	4005.88	4005.88

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	41.28	41.26	40.06	40.06	40.06
Total Share Capital	41.28	41.26	40.06	40.06	40.06

Reserves and Surplus	16259.06	14291.13	9299.84	7395.16	6115.17
Total Reserves and Surplus	16259.06	14291.13	9299.84	7395.16	6115.17
Employees Stock Options	0.00	0.00	23.19	0.00	0.00
Total Shareholders Funds	16300.34	14332.39	9363.09	7435.22	6155.23
Minority Interest	260.71	235.79	212.70	188.07	161.08

NON-CURRENT LIABILITIES
Long Term Borrowings	2821.23	5526.19	24.87	23.15	52.18
Deferred Tax Liabilities [Net]	1839.98	1812.51	89.07	77.31	55.62
Other Long Term Liabilities	101.37	34.03	30.68	30.67	20.15
Long Term Provisions	248.65	155.06	123.12	97.89	80.00
Total Non-Current Liabilities	5011.23	7527.79	267.74	229.02	207.96

CURRENT LIABILITIES
Short Term Borrowings	3383.11	2956.84	171.17	139.49	820.89
Trade Payables	1341.33	1133.40	1102.99	1008.18	1076.38
Other Current Liabilities	969.07	909.45	456.26	407.84	461.70
Short Term Provisions	813.74	663.87	389.31	307.63	264.50
Total Current Liabilities	6507.25	5663.56	2119.73	1863.14	2623.47

Total Capital And Liabilities	28079.53	27759.53	11963.25	9715.45	9147.74

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2959.61	2907.87	2936.91	2529.17	1725.14
Intangible Assets	9168.26	9604.03	1588.34	1701.46	1842.61
Capital Work-In-Progress	654.78	306.13	207.09	493.19	669.87
Intangible Assets Under Development	472.85	519.54	74.70	56.95	31.60
Fixed Assets	13255.50	13337.57	4807.04	4780.78	4269.22
Goodwill On Consolidation	6492.63	6492.63	20.02	20.02	20.44
Non-Current Investments	447.87	351.09	309.81	270.95	235.01
Deferred Tax Assets [Net]	324.70	107.89	80.40	29.78	39.29
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.03
Other Non-Current Assets	604.63	482.08	177.76	286.05	176.93
Total Non-Current Assets	21125.33	20771.26	5395.03	5387.58	4740.92


CURRENT ASSETS
Current Investments	1537.31	1690.84	2258.11	1075.47	874.46
Inventories	2144.48	2093.71	1553.46	1498.46	1760.24
Trade Receivables	1729.51	1538.34	848.28	576.42	388.17
Cash And Cash Equivalents	482.77	554.50	1197.97	453.20	405.94
Short Term Loans And Advances	4.31	3.95	2.86	1.63	1.19
OtherCurrentAssets	1055.82	1106.93	707.54	722.69	976.82
Total Current Assets	6954.20	6988.27	6568.23	4327.87	4406.82

Total Assets	28079.53	27759.53	11963.25	9715.45	9147.74

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	9140.03	5304.33	329.78	167.78	211.93

BONUS DETAILS
Bonus Equity Share Capital	0.52	0.52	0.52	0.52	0.52

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	248.03	160.19	120.52	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	89.54	235.01

CURRENT INVESTMENTS
Current Investments Quoted Market Value	1537.31	1690.84	2258.11	1075.47	874.46

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00
No. of Equity Shares (in Lacs)	4128.28

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	41.28
Total Share Capital	41.28
Reserves and Surplus	16259.06
Total Reserves and Surplus	16259.06
Employees Stock Options	0.00
Total Shareholders Funds	16300.34
Minority Interest	260.71
NON-CURRENT LIABILITIES
Long Term Borrowings	2821.23
Deferred Tax Liabilities [Net]	1839.98
Other Long Term Liabilities	101.37
Long Term Provisions	248.65
Total Non-Current Liabilities	5011.23
CURRENT LIABILITIES
Short Term Borrowings	3383.11
Trade Payables	1341.33
Other Current Liabilities	969.07
Short Term Provisions	813.74
Total Current Liabilities	6507.25
Total Capital And Liabilities	28079.53
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2959.61
Intangible Assets	9168.26
Capital Work-In-Progress	654.78
Intangible Assets Under Development	472.85
Fixed Assets	13255.50
Goodwill On Consolidation	6492.63
Non-Current Investments	447.87
Deferred Tax Assets [Net]	324.70
Long Term Loans And Advances	0.00
Other Non-Current Assets	604.63
Total Non-Current Assets	21125.33
CURRENT ASSETS
Current Investments	1537.31
Inventories	2144.48
Trade Receivables	1729.51
Cash And Cash Equivalents	482.77
Short Term Loans And Advances	4.31
OtherCurrentAssets	1055.82
Total Current Assets	6954.20
Total Assets	28079.53
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	9140.03
BONUS DETAILS
Bonus Equity Share Capital	0.52
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	248.03
Non-Current Investments Unquoted Book Value	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	1537.31

Markets

Balance Sheet

BALANCE SHEET

Mankind Pharma Ltd.